chromic phosphate has been researched along with Cancer, Second Primary in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dent, SF; Klaassen, D; Pater, JL; Whitehead, M; Zee, B | 1 |
1 trial(s) available for chromic phosphate and Cancer, Second Primary
Article | Year |
---|---|
Second primary malignancies following the treatment of early stage ovarian cancer: update of a study by the National Cancer Institute of Canada--Clinical Trials Group (NCIC-CTG).
Topics: Antineoplastic Agents, Alkylating; Brachytherapy; Canada; Chromium Compounds; Combined Modality Therapy; Disease-Free Survival; Dose Fractionation, Radiation; Female; Humans; Melphalan; Neoplasm Staging; Neoplasms, Second Primary; Ovarian Neoplasms; Phosphates; Survival Rate; Time Factors | 2000 |